Skip to main content
PMC home page
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2007 May 1;6(2):223–234. doi: 10.1111/j.1582-4934.2002.tb00189.x

Apoptosis in the immune system: 1. Fas‐induced apoptosis in monocytes‐derived human dendritic cells

Roxana Nat 1,✉, E Radu 1, T Regalia 1, L M Popescu 1
PMCID: PMC6740210  PMID: 12169207

Abstract

Dendritic cells (DC) are cells of the hematopoietic system specialized in capturing antigens and initiating T cell‐mediated immune responses. We show here that human DC generated from adherent peripheral blood mononuclear cells (PBMC) after in vitro stimulation with granulocyte macrophage colony stimulating factor (GM‐CSF) and interleukin‐4 (IL‐4) express Fas antigen (APO‐1, CD95) and can undergo apoptosis upon triggering of Fas by monoclonal antibodies. Immature monocytes‐derived dendritic cells (MDDC) upregulate CD86 and HLA‐DR expression and develop dendrites and veiled processes. Flow cytometry analysis revealed CD95 expression in approx. 40% of these MDDC and incubation with anti‐CD95 mAb (0.5μg/ml) induced apoptosis when compared to untreated controls. The extent of apoptosis induced by the agonist anti‐Fas antibody strongly related to the percentage of cells expressing CD 95. Upon tumor necrosis factor α (TNF‐α) additional stimulation, MDDC assumed a characteristic mature dendritic cells morphology showing prolonged veils, CD83 expression, and high levels of HLA‐DR. These cells have downregulated their Fas receptors (to approx. 20%) and undergo apoptosis to a lesser extent when treated with anti‐CD 95, as demonstrated by the hardly noticeable effect of this antibody on the viability of cultured cells as compared to controls. Thus, upon TNF‐α induced maturation, MDDC became resistant to Fas‐induced apoptosis. The apoptotic episodes surrounding the earlier stage of DC differentiation appeared to be mediated by Fas. In contrast, a Fas independent pathway is probably responsible for the apoptotic events associated with terminally differentiated DC.

Keywords: apoptosis, Fas (CD95/Apo1), human dendritic cells, monocytes

References

  • 1. Linette G. P. Korsmeyer S. J. Differentiation and cell death: lessons from the immune system. Curr. Opin. Biol., 6: 809, 1997. [DOI] [PubMed] [Google Scholar]
  • 2. Peter M.E., Heufelder A.E., Hengarttner M.O., Advance in apoptosis research, Proc, Natl. Acad. Sci. USA, 94, 1236–12736, 1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Uren A.G. Vaux D.L. Molecular and Clinical aspects of apoptosis, Pharmacol Ther., 72, 37–50, 1996. [DOI] [PubMed] [Google Scholar]
  • 4. Ker J.F.R., Wylie A.H., Currie A.R., Apoptosis a basic biological phenomenon with wide‐ranging implications in tissue kinetics, Br. J. Cancer, 26, 239–257, 1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Steinman R.M. The dendritic cell systme and its role in immunogenicity, Ann. Rev. Immunol., 9, 271, 1991. [DOI] [PubMed] [Google Scholar]
  • 6. Thomas R., Lipsky P.E., Dendritic cells: origin and differntiation, Stem Cells, 14, 196–206, 1996. [DOI] [PubMed] [Google Scholar]
  • 7. Lotze, MT , Thomson AW, Dendritic cells: biology and clinical applications, Academic Press, 1999. [Google Scholar]
  • 8. Romani, N , Gruner S, Brang D, Kampger E, Lenz A, et al: Proliferating dendritic cells progenitors in human blood., J. Exp. Med., 180, 83–93, 1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Romani, N. , Reider, D. , Heuer, M. , Ebner, S. , Kampgen, E. , Eibl, B. , Niederwieser, D. and Schuler, G. , Generation of mature dendritic cells from human blood ‐ an improved method with special regard to clinical aplicability, J. Immunol. Methods, 196, 137–151, 1996. [DOI] [PubMed] [Google Scholar]
  • 10. Lotze, M.T. , Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer, Ann. Surg., 226, 1–5, 1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Hart, D.N.J. , Dendritic cells: unique leukocyte populations which control the primary immune response, Blood, 90, 3245–3287, 1997. [PubMed] [Google Scholar]
  • 12. Bachereau, J and Steinman, R.M. , Dendritic cells and the control of immunity, Nature, 392, 245–252, 1998. [DOI] [PubMed] [Google Scholar]
  • 13. Griffith, T. S. , Brunner, T. , Fletcher, S. M. , Green, D. R. and Ferguson, T. A. , Fas ligandinduced apoptosis as a mechanism of immune privilege, Science 270:1189, 1996. [DOI] [PubMed] [Google Scholar]
  • 14. O'Connel, J. O'Sullivan, G.C. , Collins, J.K. and Shanahan, F. , He Fas counterattack: Fasmediated T cell killing by colon cancer cells expressing Fas ligand, J. Exp. Med., 184, 1075–1082, 1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Smith, C. , Farrah, T. and Goodwin, R. G. , The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death, Cell, 76:959, 1994. [DOI] [PubMed] [Google Scholar]
  • 16. Nagata, S. and Goldstein, P. , The Fas death factor, Science, 267:1449, 1995. [DOI] [PubMed] [Google Scholar]
  • 17. Nagata, S. , Apoptosis by death factor, Cell, 88, 355–365, 1997. [DOI] [PubMed] [Google Scholar]
  • 18. Bellgrau, D. , Gold, D. , Selawry, H. , Moore, J. , Franzusoff, A. and Duke, R. C. , A role for CD95 ligand in preventing graft rejection, Nature, 377:630, 1996. [DOI] [PubMed] [Google Scholar]
  • 19. Maciejewski, J. , Selleri, C. , Anderson, S. and Young, N. S. , Fas antigen expression on CD34 1 human bone marrow cells is induced by interferong and tumor necrosis factor and potentate's cytokine‐mediated hematopoietic suppression in vitro, Blood, 85:3183, 1995. [PubMed] [Google Scholar]
  • 20. Hahne M., Rimoldi D., Schroter M., Romero P., Schreier M., French L.E., Schneider P., Bornand T., Fontana A., Lienard D., Cerottini J.C., Tschopp J., Melanoma cell expression of Fas (Apo1/CD95) ligand; implications for tumor immune escape, Science, 274: 1363–1366, 1996. [DOI] [PubMed] [Google Scholar]
  • 21. Strand S., Hofmann W.J., Hug H., Miller M., Otto G., Strand D., Mariani S.M., Stremmel W., Krammer P.H., Galle P.R., Lymphocyte apoptosis induced by CD95 (APO‐1/Fas) ligand‐expressing tumor cells a mechanism of immune evasion?, Nature Medicine, 2: 1361–1366, 1996. [DOI] [PubMed] [Google Scholar]
  • 22. Um H.D., Orenstein, J.M. and Wahl, S.M . Fas mediated apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway, J. Immunol., 156: 3469–3477, 1996. [PubMed] [Google Scholar]
  • 23. Villunger, A. , Egle, A. , Marschitz, I. , Kos, M. , Bock, G. , Ludwig, H. , Geley, S. , Kofler, R. , and Greil, R . Constitutive expression of Fas (Apo1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor‐induced suppression of immune surveillance, Blood, 90: 12–20, 1997. [PubMed] [Google Scholar]
  • 24. Suda, T. and Nagata, S. , Purification and characterization of the Fas‐ligand that induces apoptosis, J. Exp. Med., 179:873, 1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Popescu B.O., Popescu L.M., Neuronal apoptosis trig‐gered by anti‐Fas (CD95, APO‐1) antibody is enhanced by dexamethasone, J. Med. Biochem., 4: 1–14, 2000. [Google Scholar]
  • 26. Voiculescu Bogdan, Nat. R., Lin E., Josef C., Apoptosis in human embryo development: 1. Cerebral cortex, J. Cell, Mol. Med., 4: 284–288, 2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Nat R., Voiculescu B., Stanciu C., Vidulescu C., Cergan R., Badiu C., Popescu L.M., Apoptosis in human embryo development: 2. Cerebellum, J. Cell. Mol. Med., 5: 179–187, 2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Nat., R. , Radu E., Regalia T., Popescu L.M., Apoptosis in human embryo development: 3. Fas induced apoptosis in primary brain cultures, J. Cell. Mol. Med., 5: 417–428, 2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Santiago‐Schwartz, F. , Borrero, M. , Tucci, J. , Palaia, T And Carsons, S.E. , In vivo expansion of CD13+CD33+ dendritic cells precursors from multipotent progenitors is regulated by a discrete Fas‐mediated apoptotic schedule, J. Leukocyte Biol., 62: 493–502, 1997. [DOI] [PubMed] [Google Scholar]
  • 30. Ludewig, B. , Graf, D. , Gerdelblom, H.R. , Becker, Y. , Kroczek, R.A. and Pauli, G . Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40‐ligand) and TNFa, but strongly enhanced by interleukin‐10, Eur. J. Immunol, 25: 1943–1950, 1995. [DOI] [PubMed] [Google Scholar]
  • 31. Koch, F. , Heugler, C. , Kampgen, E. , Schneeweiss, D. , Bock, G. And Schuler, G. , Tumor necrosis factor a maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colonystimulation factor, without inducing their functional maturation, J. Exp. Med., 171: 159–171, 1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Markowicz, S. and Engleman. E.G. , Granulocyte‐macrophage colony‐stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro, J. Clin. Invest., 85: 955–961, 1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Caux, C. , Massacrier, C. , Vanbervliet, B. , Duboi, B. , van Kooten, C. , Durand, I. And Banchereau, J. , Activation of human dendritic cells through CD40 cross‐linking, J. Exp. Med., 180: 1263–1272, 1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Kampgen, E. , Gold, R. , Eggert, A. , Kleudgen S., Toyka, K.V. And Brocker, E. , Evidence for apoptotic cell death within the dendritic cell system and its modulation by GM‐CSF and TNF‐α, Arch. Dermatol. Res., 286: 230a, 1994. [Google Scholar]
  • 35. Cohen, G.M. , Caspases: the executioners of apoptosis, Biochem. J., 326: 1–16, 1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Matsue, H. , Edelbaum, D. , Hartman, A.C. , Morita, A. , Bergstresser, P.R. , Okumura, K. , Yagita, H. And Takashima, A. , Dendritic cell apoptosis during antigen‐specific interaction with CD4+ T cells, J. Invest. Dermatol., 110: 488a, 1998. [PubMed] [Google Scholar]
  • 37. Lu, L. , Qian, S. , Hershberger, P.A. , Rudert, W.A. , Lynch, D.H. and Thomson, A.W. , Fas ligand (CD95L) and B7 expression of dendritic cells provide counter‐regulatory signals for T cell survival and proliferation, J. Immunol, 158: 5676–5684, 1997. [PubMed] [Google Scholar]
  • 38. Von Stebut, E. Philipp, S. , Wurz, M. And Kolde, G. , Apoptosis of cultured Langerhans cells is mediated by CD95 (APO‐1/Fas)/CD95L‐ system, J. Invest. Dermatol., 109: 406a, 1997. [Google Scholar]
  • 39. Kolde, G. , Wesendahl, C. Amd Ringling, M. , Fas ligand expression in Langerhans cell histiocytosis: evidence for an immune privileged disorder, Arch. Dermatol. Res, 290: 47a, 1998. [Google Scholar]
  • 40. Koppi, T.A. , Tough‐Bement, T. , Lewinsohn, D.M. , Lynch, D.H. and Alderson, M.R. , CD40 ligand inhibits Fas/CD95‐mediated apoptosis of human blood‐derived dendritic cells, Eur. J. Immunol, 27: 3161–3165, 1997. [DOI] [PubMed] [Google Scholar]
  • 41. Bjorck, P. , Banchereau, J. Amd Flores‐Romo, L. , CD40 ligation counteracts Fas‐induced apoptosis of human dendritic cells, Int. Immunol., 9: 365–372, 1997. [DOI] [PubMed] [Google Scholar]
  • 42. Kikuchi, A. , Franzoso, G. , Siebenlist, U. And Udey, M.C. , NfkB/Rel protein expression and activity in a model of dendritic cell (DC) activation and maturation, J. Invest. Dermatol, 110: 487a, 1998. [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES